U.S., March 22 -- ClinicalTrials.gov registry received information related to the study (NCT06888726) titled 'Efficacy of Hi-tACS for Schizophrenia Negative Symptoms' on Feb. 20.
Brief Summary: The goal of this clinical trial is to investigate whether Hi-tACS is effective and safe in treating negative symptoms of schizophrenia.
Schizophrenic patients will receive treatment (Hi-tACS or shame stimulation) for 2 weeks.
Negative symptoms, cognitive functioning, social functioning, and quality of life of intervention group and control group were assessed and compared between the two groups at baseline, 2 weeks, and 3 months post-intervention.
Study Start Date: June 27, 2024
Study Type: INTERVENTIONAL
Condition:
Schizophrenia; Negative Typ...